IMMU-02. LOCOREGIONAL HER2CAR T CELLS FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: PRECLINICAL EFFICACY TO TOLERABILITY IN FIRST PATIENT

Chimeric antigen receptor (CAR) T cell therapy provides a broadly applicable, targeted, yet pathway-independent, intervention for pediatric central nervous system (CNS) tumors. We have optimized the efficacy and specificity of a HER2-targeted CAR with an extracellular target-specific scFv domain der...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Vitanza, Nicholas, Johnson, Adam, Beebe, Adam, Gust, Juliane, Hauptman, Jason, Hoeppner, Corrine, Wilson, Ashley, Perez, Francisco, Pinto, Navin, Orenta, Rimas, Finn, Laura, Gardner, Rebecca, Park, Julie, Jensen, Michael
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Immunology/Immunotherapy
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477237/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.123
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы